Partners Group Holding Valuation
Is 0QOQ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0QOQ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0QOQ (CHF1264.76) is trading above our estimate of fair value (CHF1195.49)
Significantly Below Fair Value: 0QOQ is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0QOQ?
Other financial metrics that can be useful for relative valuation.
What is 0QOQ's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CHF 33.13b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 18.6x |
Enterprise Value/EBITDA | 29.9x |
PEG Ratio | 2.4x |
Price to Earnings Ratio vs Peers
How does 0QOQ's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 13.9x | ||
III 3i Group | 8.5x | 14.9% | UK£32.7b |
ICG Intermediate Capital Group | 14.3x | 3.9% | UK£6.7b |
SDR Schroders | 14.8x | 14.8% | UK£5.6b |
HL. Hargreaves Lansdown | 18x | 1.4% | UK£5.3b |
0QOQ Partners Group Holding | 34.5x | 14.5% | CHF 33.1b |
Price-To-Earnings vs Peers: 0QOQ is expensive based on its Price-To-Earnings Ratio (34.5x) compared to the peer average (13.9x).
Price to Earnings Ratio vs Industry
How does 0QOQ's PE Ratio compare vs other companies in the GB Capital Markets Industry?
Price-To-Earnings vs Industry: 0QOQ is expensive based on its Price-To-Earnings Ratio (34.5x) compared to the UK Capital Markets industry average (12.9x).
Price to Earnings Ratio vs Fair Ratio
What is 0QOQ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 34.5x |
Fair PE Ratio | 23.9x |
Price-To-Earnings vs Fair Ratio: 0QOQ is expensive based on its Price-To-Earnings Ratio (34.5x) compared to the estimated Fair Price-To-Earnings Ratio (23.9x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CHF 1,264.76 | CHF 1,273.80 +0.7% | 9.2% | CHF 1,650.00 | CHF 1,120.00 | n/a | 15 |
Sep ’25 | CHF 1,228.71 | CHF 1,276.29 +3.9% | 5.7% | CHF 1,390.00 | CHF 1,150.00 | n/a | 14 |
Aug ’25 | CHF 1,184.50 | CHF 1,290.77 +9.0% | 5.4% | CHF 1,390.00 | CHF 1,150.00 | n/a | 13 |
Jul ’25 | CHF 1,149.00 | CHF 1,281.85 +11.6% | 7.3% | CHF 1,450.00 | CHF 1,150.00 | n/a | 13 |
Jun ’25 | CHF 1,208.20 | CHF 1,276.31 +5.6% | 8.7% | CHF 1,450.00 | CHF 1,040.00 | n/a | 13 |
May ’25 | CHF 1,189.50 | CHF 1,257.38 +5.7% | 9.5% | CHF 1,450.00 | CHF 1,040.00 | n/a | 13 |
Apr ’25 | CHF 1,283.70 | CHF 1,240.23 -3.4% | 9.2% | CHF 1,450.00 | CHF 1,040.00 | n/a | 13 |
Mar ’25 | CHF 1,264.69 | CHF 1,181.64 -6.6% | 10.0% | CHF 1,360.00 | CHF 920.00 | n/a | 14 |
Feb ’25 | CHF 1,174.62 | CHF 1,155.21 -1.7% | 9.4% | CHF 1,350.00 | CHF 920.00 | n/a | 14 |
Jan ’25 | CHF 1,213.05 | CHF 1,097.57 -9.5% | 11.5% | CHF 1,289.00 | CHF 860.00 | n/a | 14 |
Dec ’24 | CHF 1,155.74 | CHF 1,081.57 -6.4% | 11.3% | CHF 1,289.00 | CHF 860.00 | n/a | 14 |
Nov ’24 | CHF 966.75 | CHF 1,054.64 +9.1% | 11.6% | CHF 1,289.00 | CHF 860.00 | n/a | 14 |
Oct ’24 | CHF 1,034.74 | CHF 1,054.64 +1.9% | 11.6% | CHF 1,289.00 | CHF 860.00 | n/a | 14 |
Sep ’24 | CHF 959.40 | CHF 1,019.84 +6.3% | 15.0% | CHF 1,491.00 | CHF 860.00 | CHF 1,228.71 | 14 |
Aug ’24 | CHF 980.00 | CHF 1,018.51 +3.9% | 14.5% | CHF 1,491.00 | CHF 860.00 | CHF 1,184.50 | 15 |
Jul ’24 | CHF 840.73 | CHF 992.22 +18.0% | 8.5% | CHF 1,120.03 | CHF 848.00 | CHF 1,149.00 | 14 |
Jun ’24 | CHF 819.24 | CHF 960.08 +17.2% | 16.2% | CHF 1,120.03 | CHF 480.11 | CHF 1,208.20 | 15 |
May ’24 | CHF 859.20 | CHF 946.80 +10.2% | 16.4% | CHF 1,100.00 | CHF 480.11 | CHF 1,189.50 | 14 |
Apr ’24 | CHF 853.81 | CHF 985.41 +15.4% | 20.5% | CHF 1,491.00 | CHF 480.11 | CHF 1,283.70 | 15 |
Mar ’24 | CHF 881.50 | CHF 1,015.69 +15.2% | 20.8% | CHF 1,491.00 | CHF 480.11 | CHF 1,264.69 | 15 |
Feb ’24 | CHF 861.79 | CHF 1,015.69 +17.9% | 20.8% | CHF 1,491.00 | CHF 480.11 | CHF 1,174.62 | 15 |
Jan ’24 | CHF 827.32 | CHF 1,137.11 +37.4% | 21.1% | CHF 1,540.00 | CHF 480.11 | CHF 1,213.05 | 15 |
Dec ’23 | CHF 943.40 | CHF 1,153.51 +22.3% | 20.8% | CHF 1,540.00 | CHF 480.11 | CHF 1,155.74 | 14 |
Nov ’23 | CHF 912.29 | CHF 1,162.65 +27.4% | 20.6% | CHF 1,540.00 | CHF 480.11 | CHF 966.75 | 14 |
Oct ’23 | CHF 804.60 | CHF 1,255.67 +56.1% | 17.3% | CHF 1,590.00 | CHF 765.40 | CHF 1,034.74 | 14 |
Sep ’23 | CHF 908.80 | CHF 1,279.29 +40.8% | 17.1% | CHF 1,600.00 | CHF 765.40 | CHF 959.40 | 15 |
Analyst Forecast: Target price is less than 20% higher than the current share price.